The MDM2 inducible promoter folds into four-tetrad antiparallel G-quadruplexes targetable to fight malignant liposarcoma

Nucleic Acids Res. 2021 Jan 25;49(2):847-863. doi: 10.1093/nar/gkaa1273.

Abstract

Well-differentiated liposarcoma (WDLPS) is a malignant neoplasia hard to diagnose and treat. Its main molecular signature is amplification of the MDM2-containing genomic region. The MDM2 oncogene is the master regulator of p53: its overexpression enhances p53 degradation and inhibits apoptosis, leading to the tumoral phenotype. Here, we show that the MDM2 inducible promoter G-rich region folds into stable G-quadruplexes both in vitro and in vivo and it is specifically recognized by cellular helicases. Cell treatment with G-quadruplex-ligands reduces MDM2 expression and p53 degradation, thus stimulating cancer cell cycle arrest and apoptosis. Structural characterization of the MDM2 G-quadruplex revealed an extraordinarily stable, unique four-tetrad antiparallel dynamic conformation, amenable to selective targeting. These data indicate the feasibility of an out-of-the-box G-quadruplex-targeting approach to defeat WDLPS and all tumours where restoration of wild-type p53 is sought. They also point to G-quadruplex-dependent genomic instability as possible cause of MDM2 expansion and WDLPS tumorigenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis
  • Cell Cycle
  • Cell Line, Tumor
  • Computer Simulation
  • G-Quadruplexes*
  • Gene Expression Regulation, Neoplastic / genetics*
  • Humans
  • Ligands
  • Liposarcoma / therapy*
  • Models, Genetic
  • Molecular Targeted Therapy*
  • Neoplasm Proteins / metabolism
  • Nuclear Proteins / metabolism
  • Promoter Regions, Genetic / genetics*
  • Protein Interaction Mapping
  • Proteolysis
  • Proto-Oncogene Proteins c-mdm2 / biosynthesis
  • Proto-Oncogene Proteins c-mdm2 / genetics*
  • Soft Tissue Neoplasms / therapy*
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • Ligands
  • Neoplasm Proteins
  • Nuclear Proteins
  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • MDM2 protein, human
  • Proto-Oncogene Proteins c-mdm2